What the canonical reviews haven't absorbed yet — a 2023–2026 scan.
🔍 Search the corpus · 📂 Browse papers · 🦠 Virus hubs · 🕷️ Varroa · 🏠 Home
This page synthesises a structured scan of 357 recent (2023–2026), open-access, lightly-cited papers — the work that the well-cited reviews underpinning the rest of this wiki have not yet absorbed. Each paper was triaged against the archive's established-consensus baseline and tagged new, contradicts, extends, confirms, or not-relevant. The scan surfaced 177 notable findings (87 new, 78 extensions, 12 contradictions). Citations link to each paper's DOI; this is a curated review, not an exhaustive systematic one — read the Methods & caveats before acting on any single result.
The most-cited literature gives a settled picture: Varroa is the master pest, it amplifies and vectors DWV, the answer is mite control plus tolerant stock. The recent, lightly-cited frontier mostly confirms that — but it also qualifies it in twelve specific places and opens several genuinely new lines of attack. The six biggest themes:
- A wave of direct antiviral therapeutics that don't depend on killing the mite — orally-fed antibodies, gut-binding peptides, RNAi products, and surface/wax decontamination.
- The host's own antiviral machinery is being mapped — specific genes and pathways (arginine kinase, snapin, SIRT1, m6A methylation, AF9, melittin) that viruses exploit or that restrict them, i.e. new drug-style targets.
- Emerging and overlooked pathogens and non-Varroa vectors — a Varroa-vectored lethal bacterium, a confirmed bee orthomyxovirus, parasitoid and phorid flies, flower and acarid mites, and plant/insect reservoirs.
- Breeding is moving past hygiene — a heritable "suppressed-of-virus" trait, VSH stock that also resists brood disease, and microbiome links to resistance.
- Treatment-efficacy reality checks — resistance alleles approaching fixation, oxalic-glycerin out-performing summer formic acid, and field safety data for RNAi acaricides.
- Transmission ecology is being rewritten at landscape scale — honey bees as the reservoir that drives virus prevalence in wild pollinators, with spillover often a dead end.
A cross-cutting motif runs through all of it: virus × stressor interactions — heat, nutrition form, and pesticides repeatedly change the outcome of an infection.
If you read nothing else, read §2 (the contradictions) and the shortlist in §4.
What this is. A triage of 357 papers from the archive index that are recent (2023–2026), open-access, and lightly cited (≤3 citations) — i.e. work selected because it is too new or too niche to have entered the canonical reviews. Each was read against a 301-claim consensus baseline distilled from the archive's 32 evidence packs and classified by topic.
What "notable" means. Contradicts = conflicts with or qualifies a baseline claim. New = a finding, method, or mechanism absent from the baseline. Extends = adds quantitative precision, a new geography/host/condition, or a boundary condition. Of 357 papers: 87 new, 78 extends, 12 contradicts, 29 confirms, 151 not-relevant.
A data-quality note. The 151 not-relevant papers (≈42%) were mostly keyword mis-tags in the source index — human-medicine, non-bee insect virology, and sequence-deposit notes pulled in by acronym collisions (especially under "IAPV" and the mixed pool). This is itself worth knowing: the index trades precision for recall, so the corpus needs this kind of filtering.
Confidence labels are the reviewer's. "High" means the claim was clearly stated and reasonably supported in its source — not that the study is definitive. Most single-study findings, and every contradiction, deserve confirmation before they change practice.
These matter most: each is recent work pushing back on something the well-cited literature treats as settled. Read together, they suggest several "settled" generalisations are more dose-, route-, region-, and confound-dependent than the textbook phrasing admits.
- DWV-B may be less virulent than DWV-A, not more. Matched infectious clones gave 20% vs 80% pupal mortality, with most low-dose DWV-B bees asymptomatic — the reverse of the widely-cited "DWV-B is the more virulent, displacing variant." Caveat: pupal-injection model, dose-dependent. (Barth 2024)
- Natural DWV infection does not impair learning the way injected DWV does. Naturally-infected foragers showed no simple-learning deficit and better reversal learning at higher viral load — challenging a canonical claim built largely on artificially-injected bees. (Szymański 2024; mechanism echoed in a mushroom-body study, Loughran 2025)
- Varroa is no longer its own family. Combined mitochondrial + nuclear phylogeny reclassifies Varroa out of Varroidae and into Laelapidae (subfamily Varroinae) — a taxonomic correction to the baseline. (Oh 2024)
- Bee-protective pesticide "mitigation measures" are largely untested. A systematic review found that no currently-used mitigation measure had been thoroughly tested and some lacked any empirical support — undercutting the assumption that label mitigations meaningfully protect bees. (Straw 2023)
- Climate can out-predict mite load for virus intensity. In a multi-year Canadian dataset, Varroa abundance did not improve model fit for any of nine viruses; temperature was the better predictor at low infestation. (McAfee 2025)
- Enterococcus faecalis can actively facilitate sacbrood, rather than being a benign secondary invader — >45-fold enrichment and metabolic reprogramming that damages the gut and boosts CSBV. (A. cerana/CSBV context.) (Deng 2025)
- DWV-B did not replace DWV-A in Africanized bees over 2010–2019 in the Yucatán; DWV-A stayed dominant, attributed to superinfection exclusion — a tropical exception to the DWV-B-rising narrative. (Fleites-Ayil 2025)
- A monofloral diet matched or beat polyfloral for vitellogenin, lifespan, and immune-gene expression in one study — against the "polyfloral is always better" rule. (Diedrick 2025) A second study likewise found sunflower's benefit was parasite-specific (lower Varroa) with no effect on DWV/BQCV. (Husband 2025)
- Host genetic diversity gave no protection — and tracked higher DWV-B/SBPV prevalence — in bumble bees, against the diversity-resists-disease prediction. (Dobelmann 2025)
- An induced cold-storage brood break gave no lasting mite/virus benefit in one trial, whereas resistant stock cut mites >65% — a boundary condition on the "broodless window boosts efficacy" principle. (Meikle 2026)
- Hygienic workers are not socially quarantined. After handling diseased brood they kept normal trophallaxis centrality and would spread a simulated infection as widely as non-hygienic bees — complicating the organizational-immunity picture and hinting hygienic bees could be a within-colony transmission route. (Perez 2025)
- Some observational field data point the "obvious" way and the wrong way at once: in one 43-colony survey amitraz use associated with higher DWV and richer forage with higher viral load. Confidence: low — sicker colonies get treated and sampled; treat as hypothesis only. (Malay 2025)
Terse, citation-anchored. The full machine-readable list (with verbatim supporting quotes for every paper) lives in the corpus alongside this review.
The single largest cluster of new work — treatments that target the virus or the host, breaking the "control the mite to control the virus" dependency.
- Orally-fed anti-DWV antibodies (IgY) cut DWV ~8× in naturally-infected bees, reaching the haemolymph from the gut. (MacMillan 2024) The same passive-immunotherapy idea appears against sacbrood (Li 2023) and Nosema (Açık 2024).
- A gut-binding peptide (BBP2.1) competitively blocks DWV/IAPV attachment to the midgut and reduced DWV movement after oral dosing. (Guo 2025)
- RNAi maturing into products: mechanism and bee-safety data for the calmodulin-targeting acaricide vadescana (Smeele 2026, Merk 2026); oral dsRNA against SBV (Chang 2025) and ABPV (Ferrufino 2025).
- Surface & wax decontamination: cold-plasma ionized H₂O₂ inactivates surface DWV ~10⁵-fold (Cook 2023, Diego 2024); simple wax storage ≥30 days (or e-beam) reduces waxborne BQCV/DWV (Colwell 2024).
- Other antiviral leads: a chitosan–propolis nanocomposite lowered DWV in cell culture (Seyam 2026); a SIRT1 activator extended cold-stressed bee lifespan (Zhang 2023); hive-derived lactic-acid-bacteria postbiotics reduced Varroa viability, best with oxalic acid (García-Vicente 2024).
Recent work names specific host genes and pathways that viruses exploit or that restrict them — the raw material for future host-directed therapeutics.
- Arginine kinase is co-opted by DWV; silencing it via RNAi lowers viral load. (Becchimanzi 2025)
- Snapin binds DWV capsid VP2; knockdown reduces replication. (Sun 2023)
- m6A RNA methylation is a battleground: METTL3 restricts sacbrood (Liu 2025), and the virus in turn weaponises it to suppress the immune gene AF9, which also restricts DWV and ABPV (Bai 2025).
- A Varroa salivary cystatin manipulates host pupal metabolism — a defined virulence factor beyond feeding and virus transfer. (Zhou 2023)
- Melittin "venom bathing" is an external-immunity layer that Varroa parasitism impairs. (Pusceddu 2025)
- DWV directly causes immunosuppression and gut dysbiosis (shown by injection, independent of the mite). (Becchimanzi 2026) Antioxidant defence underlies larval CSBV resistance. (Lü 2025)
¶ 3c. Emerging & overlooked pathogens and vectors
- Morganella morganii — a lethal bacterium that is vectored by Varroa (92% bee-to-mite transmission) but not bee-to-bee: a genuinely new disease axis. (Chen 2025)
- Apis orthomyxovirus 1 confirmed as a real replicating pathogen (it also infects Varroa), alongside a novel "apthili" virus higher in winter survivors. (Deboutte 2024)
- IAPV is an emerging brood pathogen of Apis cerana, not just A. mellifera. (Xie 2024) The 2024–25 US collapse was dominated by an ABPV surge (72% of colonies) plus DWV, with universal amitraz-resistance alleles in the mites. (Lamas 2026)
- Non-Varroa arthropod carriers: parasitoid and phorid flies (Rossi 2024, Ruiz-Guzmán 2026); acarid/flower mites Tyrophagus (Nguyen 2023), Neocypholaelaps (Nguyen 2024), and Euvarroa on A. florea (Tian 2023); hornets as silent carriers of ABPV/DWV (Gál 2025).
- Apis mellifera filamentous virus (AmFV) emerging and Varroa-borne, with host-associated lineages. (Nguyen 2024, Cornman 2023)
- Novel viruses in declining colonies — undescribed partitivirus-like sequences and a new Lake Sinai virus (Jones 2026); new regional viromes (Hamim 2025, Kim 2026).
- Reservoirs beyond the hive: BQCV in mosquitoes (Baril 2023), KBV in papaya tissue (Faúndez-Acuña 2025), DWV-B causing the first clinical symptom reported in spiders (Schläppi 2023).
- A heritable "suppressed-of-virus" (SOV) trait: ten years of Flemish breeding raised SOV-positive queens 57%→85% and directly cut DWV/BQCV/ABPV/SBV prevalence and load, independent of mite-resistance traits. (Bossuyt 2026)
- VSH stock resists brood disease too — Pol-line bees resisted chalkbrood as well as hygienic-selected stock while carrying fewer mites. (Dyrbye-Wright 2025)
- Resistance markers are population-specific — the standard mite-non-reproduction MAS markers vary by subspecies and need per-race re-validation. (Lefebre 2024)
- Mechanistic handles on resistance: divergent brood-ester pheromones in resistant Gotland bees (Scaramella 2024); virus-associated recapping (Noël 2026); mite-biting that targets the mite's chemosensory forelegs (Mukogawa 2024); reduced larval attractiveness in feral resistant stock (Chong-Echavez 2026).
- Microbiome ↔ resistance: gut-bacterial composition tracks hygienic-behaviour expression (De 2026, Tola 2025); a native Snodgrassella strain suppressed DWV (Zhou 2025).
- A caution worth heeding: survival-based "Darwinian" beekeeping selects for tolerance (unchanged viral load), not resistance — sustaining reservoirs and possibly selecting for virulence in wild bees. (Sokolov 2025)
- Resistance is approaching fixation: pyrethroid kdr at ~83% homozygous (up to 94% regionally) in Türkiye (Yalcin 2026); a universal amitraz-resistance allele (Octβ2R Y215H) in all mites of the 2024–25 US collapse sample (Lamas 2026).
- Oxalic-glycerin strips (55.8%) beat summer formic acid (42.6%) and oxalic dribble (39.5%) in a northern-continental summer window — reversing the expectation that brood-penetrating formic leads in summer. (Thurston 2025)
- Monitoring is non-negotiable: at US-state scale, treating without monitoring was no more protective than not treating. (Boehm 2025)
- Oxalic acid biology revised — it is constitutively present in haemolymph and activates the immune/antioxidant system rather than simply being a contact poison. (Sagona 2024)
- Formic Pro stimulated hygienic behaviour alongside 88% efficacy (Ristanić 2025); novel delivery (thyme nanoemulsion, eucalyptus coil) raised essential-oil efficacy in small trials (Güneşdoğdu 2026, Al-Hayali 2025).
- Honey bees are the landscape viral reservoir: wild-pollinator virus prevalence is driven by honey-bee viral density and niche overlap, while high wild-pollinator abundance can dilute DWV-B. (Proesmans 2026)
- Spillover is often a dead end — honey-bee viruses in bumble bees showed no diversification over three years (>98% identity), arguing against host-range expansion. (McKeown 2025)
- Apiary-scale dynamics: colony loss tracked adjacency to fast-growing-Varroa neighbours more than a colony's own mite growth (Bartlett 2024); 17–48% of final mite load came from immigration, biasing resistance phenotyping (Guichard 2024).
- Population-genetic consequences: Varroa independently raised commercial-lineage introgression on the Azores. (Henriques 2025)
- Heat × IAPV degrades drone sperm viability — a fertility cost of co-occurring heat and virus. (McAfee 2025)
- Diet form × DWV: free-amino-acid diets raised DWV and early mortality versus intact protein, despite good nutrition biomarkers. (Tapia-Rivera 2025)
- Foraging breadth sets the stressor syndrome: diverse foraging raises pathogen exposure while narrow foraging raises xenobiotic exposure — a trade-off, not a clean "diversity is protective." (Wizenberg 2024)
- Sublethal behaviour: covert DWV and SBV have opposite effects on flight, and octopamine rescues the DWV deficit (Kaku 2025); DWV pushes precocious foraging and lowers nectar quality (Ferreira 2025).
- Non-invasive surveillance: hive debris as an apiary-level RT-PCR matrix (Olivieri 2025); honey as a broad bee-virus matrix (Tiritelli 2025); a detectable VOC "smell of infection" for Vairimorpha (Asiri 2026); egg sampling as a queen-mother virus indicator (Domingues 2024).
- Queen pathway to colony collapse: DWV-B + BQCV shrink queen ovaries, lowering the pheromone methyl oleate and triggering worker supersedure. (McAfee 2025)
- Priming: N. ceranae oral immune priming cut later spore loads up to 97% (Nieh 2025); transgenerational immune priming via the egg (Chapman 2025).
- Biosecurity: an intercepted A. dorsata swarm carried Tropilaelaps that survived an extended brood-free shipboard period — a long-distance dispersal risk. (Ramirez 2026)
Biased toward high confidence and direct practical relevance:
- Oral anti-DWV antibodies cut DWV ~8× — MacMillan 2024
- Varroa-vectored lethal Morganella (new disease axis) — Chen 2025
- Pyrethroid resistance near fixation (Türkiye) — Yalcin 2026
- Oxalic-glycerin beats summer formic — Thurston 2025
- SOV breeding directly lowers virus loads — Bossuyt 2026
- DWV-B may be less virulent than DWV-A — Barth 2024
- DWV co-opts arginine kinase (new target) — Becchimanzi 2025
- Treating without monitoring ≈ not treating — Boehm 2025
- DWV directly causes immunosuppression + dysbiosis — Becchimanzi 2026
- Honey bees are the landscape viral reservoir — Proesmans 2026
- 2024–25 US collapse = mite-vectored viruses — Lamas 2026
- Pesticide mitigation measures untested — Straw 2023
- vadescana RNAi: mechanism + bee safety — Smeele 2026, Merk 2026
- Feral resistant stock matches treated colonies — Chong-Echavez 2026
- Tropilaelaps biosecurity / swarm interception — Ramirez 2026
These are pointers, not rewrites — the established topic pages still hold; this is where recent work adds to or pushes against them.
- DWV: the DWV-A/B virulence question is genuinely open (Barth 2024, Fleites-Ayil 2025); the learning-impairment claim needs the natural-vs-injected caveat (Szymański 2024); add direct antivirals and host targets (MacMillan 2024, Guo 2025, Becchimanzi 2025, Becchimanzi 2026).
- Varroa overview: note the Laelapidae reclassification (Oh 2024) and Varroa as a bacterial vector (Chen 2025).
- Acaricides & resistance: resistance trajectories (Yalcin 2026, Lamas 2026); oxalic-glycerin-vs-formic (Thurston 2025); revised oxalic biology (Sagona 2024).
- Breeding for resistance: the SOV trait (Bossuyt 2026), VSH-vs-brood-disease (Dyrbye-Wright 2025), population-specific markers (Lefebre 2024), and the tolerance-vs-resistance caution (Sokolov 2025).
- Emerging actives: RNAi product data (Smeele 2026, Merk 2026).
- Virus hub: IAPV in A. cerana (Xie 2024), the 2024–25 ABPV surge (Lamas 2026), and new viromes/orthomyxovirus (Deboutte 2024, Jones 2026).
- Nosema: immune priming (Nieh 2025) and the E. faecalis contradiction (Deng 2025).
- Pesticides: mitigation-untested (Straw 2023) and the foraging-breadth trade-off (Wizenberg 2024).
- Nutrition: diet-form × DWV (Tapia-Rivera 2025) and the monofloral caveat (Diedrick 2025).
This review triages recent abstracts and full texts against a fixed baseline; it is not a substitute for reading the primary papers, and every contradiction above deserves independent confirmation before it changes practice. Compiled 2026-06-23.